BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23394154)

  • 21. Nanomedicine: novel approaches in human and veterinary therapeutics.
    Irache JM; Esparza I; Gamazo C; Agüeros M; Espuelas S
    Vet Parasitol; 2011 Aug; 180(1-2):47-71. PubMed ID: 21680101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines.
    Greco F; Vicent MJ
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1203-13. PubMed ID: 19699247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial nanomedicine.
    Yacoby I; Benhar I
    Nanomedicine (Lond); 2008 Jun; 3(3):329-41. PubMed ID: 18510428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
    Bertalan F; László B; Attila V
    Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conference scene: Nanoneuroprotection and nanoneurotoxicity: recent progress and future perspectives.
    Sharma HS; Sharma A
    Nanomedicine (Lond); 2010 Jun; 5(4):533-7. PubMed ID: 20528449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurosurgery in the realm of 10(-9), Part 2: applications of nanotechnology to neurosurgery--present and future.
    Elder JB; Liu CY; Apuzzo ML
    Neurosurgery; 2008 Feb; 62(2):269-84; discussion 284-5. PubMed ID: 18382306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug delivery systems using nano-sized drug carriers].
    Nakayama M; Okano T
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):935-40. PubMed ID: 16044950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shape-specific polymeric nanomedicine: emerging opportunities and challenges.
    Tao L; Hu W; Liu Y; Huang G; Sumer BD; Gao J
    Exp Biol Med (Maywood); 2011 Jan; 236(1):20-9. PubMed ID: 21239732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanotheranostics and image-guided drug delivery: current concepts and future directions.
    Lammers T; Kiessling F; Hennink WE; Storm G
    Mol Pharm; 2010 Dec; 7(6):1899-912. PubMed ID: 20822168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The future of biomedical materials.
    Anderson JM
    J Mater Sci Mater Med; 2006 Nov; 17(11):1025-8. PubMed ID: 17122914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant protein-based polymers for advanced drug delivery.
    Frandsen JL; Ghandehari H
    Chem Soc Rev; 2012 Apr; 41(7):2696-706. PubMed ID: 22344293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nanocage for nanomedicine: polyhedral oligomeric silsesquioxane (POSS).
    Ghanbari H; Cousins BG; Seifalian AM
    Macromol Rapid Commun; 2011 Jul; 32(14):1032-46. PubMed ID: 21598339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translational Multi-Disciplinary Approach for the Drug and Gene Delivery Systems for Cancer Treatment.
    Nayak R; Meerovich I; Dash AK
    AAPS PharmSciTech; 2019 Apr; 20(4):160. PubMed ID: 30968269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smart polymersomes for therapy and diagnosis: fast progress toward multifunctional biomimetic nanomedicines.
    De Oliveira H; Thevenot J; Lecommandoux S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(5):525-46. PubMed ID: 22761061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review: nanoparticles in drug delivery for the treatment of cancer.
    Arayne MS; Sultana N
    Pak J Pharm Sci; 2006 Jul; 19(3):258-68. PubMed ID: 16935836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecularly imprinted polymers in drug delivery: state of art and future perspectives.
    Puoci F; Cirillo G; Curcio M; Parisi OI; Iemma F; Picci N
    Expert Opin Drug Deliv; 2011 Oct; 8(10):1379-93. PubMed ID: 21933031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nanomedicine in otorhinolaryngology--future prospects].
    Dürr S; Tietze R; Lyer S; Alexiou C
    Laryngorhinootologie; 2012 Jan; 91(1):6-12. PubMed ID: 22231960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological barriers and nanomedicine--timely challenges in advanced drug delivery research.
    Lehr CM
    Eur J Pharm Biopharm; 2009 Jun; 72(2):287-8. PubMed ID: 19362591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.